May 22, 2019--Fewer deaths and serious illnesses have occurred in the U.S. over the past decade as a result of cleaner air, according to a new report focusing on the two most potent air pollutants: fine particle (PM2.5) and ground-level ozone (O3). However, these improvements are almost entirely due to reductions in PM2.5 pollution.
The report, presented at ATS 2019 and published online in the Annals of the American Thoracic Society, is the latest in the annual "Health of the Air" series produced by the American Thoracic Society and the Marron Institute at NYU. The series estimates health impacts from air pollution for every U.S. city.
In "Trends in Excess Morbidity and Mortality Associated with Air Pollution above ATS-Recommended Standards, 2008 to 2017," researchers report that mortality impacts of air pollution above these ATS-recommended levels fell by nearly half in the last decade as most U.S. counties have seen significant improvements in PM2.5, while health impacts from O3 pollution has "remained stubbornly high."
The report's findings are based on the ATS's recommendations for PM2.5 (11 micrograms per cubic meter for annual concentrations and 25 micrograms per cubic meter for short-term concentrations) and O3 (60 parts per billion), which are more protective than those adopted by the U.S. Environmental Protection Agency.
Using air quality data from more than 500 counties with PM2.5 data and more than 700 counties with O3 data, the researchers estimated the annual health impacts from air pollution from 2008-17. In 2017, the most recent year that pollution data is available, the number of excess deaths from air pollution were:
- 7,140 excess deaths from both pollutants combined, down from 12,600 excess deaths in 2010;
- 3,260 excess deaths from PM2.5, down from 8,330 excess deaths in 2010;
- 3,880 excess deaths from O3, down from 4,270 excess deaths in 2010.
Based on the levels of the two pollutants, the researchers also quantified serious illnesses (morbidities) and missed school and work days (impacted days). In 2017, the most recent year that pollution data is available, PM2.5 pollution above recommended levels was estimated to cause an additional 5,600 morbidities and 2,804,000 impacted days. That same year, O3 pollution above recommended levels was estimated to cause 10,080 morbidities and 11,600,000 impacted days.
Future Health of the Air
The latest report found that in addition to the lack of consistent improvement in the health impacts associated with O3, the rate of improvement for PM2.5 pollution has also started to level off. Without further efforts at the federal and local levels to reduce the two air pollutants, it is likely that the health impacts from air pollution could increase over time as populations grow, according to the authors.
The report also highlighted other challenges to reducing deaths and illness due to air pollution.
"The proposed roll back of several Clean Air Act regulations and the proposed roll back of the greenhouse gas standard for automobiles will make it hard for communities to maintain their air quality, and even harder for cities with poor air quality to clean up," said report co-author Gary Ewart, MHS, chief of ATS advocacy and government relations.
The authors also noted that the effects of wildfires contributing to pollution levels above EPA regulatory levels were excluded from the study, but their increasing frequency and severity may limit the improvements in health that cities and counties can achieve by reducing other air pollution sources.
Ground-level ozone occurs when sunlight causes a chemical reaction among so-called precursor pollutants, primarily nitric oxides and volatile organic compounds, and forms ozone molecules.
Recently, the U.S. Environment Protection Agency designated many locations in the country as "being in nonattainment" of the national ambient air quality standard for ozone. States that do not show improvement in the next three years will be required to develop a plan for achieving attainment.
"The large number of adverse health impacts attributable to ozone should motivate cities and states to start now to reduce their local emissions of precursors pollutants," said lead author Kevin Cromar, PhD, director of the Air Quality Program at the Marron Institute and associate professor of population health and environmental medicine at the NYU School of Medicine. "Coordinated actions at the regional level, as well as strong actions at the federal level, will also be needed in order to make consistent gains in reducing ozone in many parts of the country."
Online Tool for Cities
The latest report is also available online at http://www.
Both the report and the online tool identify the top ten cities for adverse health impacts from PM2.5 and O3:
Rank City Annual Excess Mortality
(PM2.5 and O3) Ranking in 2010
1 Los Angeles-Long Beach-Glendale, CA 1,322 1
2 Riverside-San Bernardino-Ontario, CA 940 2
3 Bakersfield, CA 293 6
4 Pittsburgh, PA 232 3
5 Fresno, CA 225 11
6 New York-Jersey City-White Plains, NY-NJ 188 5
7 Phoenix-Mesa-Scottsdale, AZ 152 19
8 Visalia-Porterville, CA 131 23
9* Cleveland-Elyria, OH 116 8
10* Chicago-Naperville-Arlington Heights, IL 122 4
*Rankings based on a weighting of the combined health impacts of air pollution, including mortality, lung cancer, morbidity and impacted days.
More information on the annual health impacts from 2010-17 for every city and county with an air pollution monitor is also available in the supplementary materials that accompany the published report.
Contact for Media
Kevin Cromar, PhD
About the Marron Institute for Urban Management at New York University
The Marron Institute conducts innovative applied research and works with cities to take on critical challenges of urban living including urban expansion, crime and justice, performance in the public sector, and environmental challenges. The Air Quality Program at the Marron Institute is led by Dr. Kevin Cromar and works to improve the health and welfare of urban residents by generating and disseminating knowledge needed to improve air quality management. Find out more at: http://marroninstitute.
About the Annals of the American Thoracic Society
The AnnalsATS is a peer-reviewed journal published by the American Thoracic Society. The Journal delivers up-to-date and authoritative coverage of adult and pediatric pulmonary and respiratory sleep medicine and adult critical care. The scope of the Journal encompasses content that is applicable to clinical practice, the formative and continuing education of clinical specialists and the advancement of public health. In October 2018, the journal received its first impact factor with a ranking of 4.006.
Editor: David Lederer, MD, MS, associate professor of medicine and epidemiology and associate division chief for clinical and translational research at Columbia University.
About the American Thoracic Society
Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society's 15,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.